Cosponsor
Sign in

HR 340 · in committee · significant

The HCT/P Modernization Act of 2025

What this bill does

  • The FDA must provide information and report on how it regulates human cell and tissue products used in medical treatments.
  • Medical device manufacturers, researchers, and healthcare providers who work with human cell and tissue products are affected.
  • The FDA will hold workshops, create a public comment docket, and publish annual data on inquiries and inspections over three years.

Generated by claude-haiku-4-5

Community Threads

Started by Cosponsor

  1. 01

    How might increased FDA transparency on human cell and tissue product regulation affect innovation timelines for medical device manufacturers?

  2. 02

    What specific gaps in current FDA oversight of these products does the bill's reporting requirement aim to reveal?

  3. 03

    How could annual inspection and inquiry data help healthcare providers make better decisions about which cell and tissue products to use in treatment?

Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.

Sponsor · R-TX-2

Dan Crenshaw

Citizen cosponsors

0

In Congress

1/ 435

House Reps cosponsoring

Introduced 2025-01-13

Joining the bill

Legislative timeline

  1. 2025-01-13 · house · IntroReferral

    Referred to the House Committee on Energy and Commerce.

  2. 2025-01-13 · IntroReferral

    Introduced in House

  3. 2025-01-13 · IntroReferral

    Introduced in House

Congress.gov ↗

Citizen comments

Sign in to comment on this bill.

No comments yet — be the first.